Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126167441 | 12616744 | 1 | I | 20160801 | 20160802 | 20160802 | PER | US-009507513-1608USA001281 | MERCK | 0.00 | M | Y | 0.00000 | 20160802 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126167441 | 12616744 | 1 | PS | INTRON A | INTERFERON ALFA-2B | 1 | Subcutaneous | 17 MILLION UNITS | 103132 | SOLUTION FOR INJECTION | |||||||||
| 126167441 | 12616744 | 2 | C | ATENOLOL. | ATENOLOL | 1 | 0 | ||||||||||||
| 126167441 | 12616744 | 3 | C | BIOTIN | BIOTIN | 1 | 0 | ||||||||||||
| 126167441 | 12616744 | 4 | C | ONDANSETRON HYDROCHLORIDE. | ONDANSETRON HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126167441 | 12616744 | 5 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 126167441 | 12616744 | 6 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126167441 | 12616744 | 7 | C | RESTASIS | CYCLOSPORINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126167441 | 12616744 | 1 | Malignant melanoma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126167441 | 12616744 | Alopecia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |